Monday, August 19, 2013
Japanese investors think Prime
Minister Shinzo Abe's "third arrow" economic liberalization plan,
along with his party's control of both houses of legislature, could mean help
is on the way for the country's tiny biotech venture space.
Change will not happen
overnight given how deeply the challenges run, but the proposals could be
adopted as soon as this fall and could have an impact starting next year.